Tag: CNS

July–August e-edition

July–August e-edition

| July 1, 2017 | 0 Comments

Click here to access e-Edition PDFs can be downloaded and printed from the e-Editions. Click on the above issue issue, find the article, then click on the print command. For archived e-editions, click on the image above, then click on the folder icon at the top of the window.  

Continue Reading

Current e-Edition

Current e-Edition

| June 1, 2017 | 0 Comments

CLICK HERE TO ACCESS E-EDITION PDFs can be downloaded and printed from the e-Editions. Click on the above issue issue, find the article, then click on the print command. For archived e-editions, click on the image above, then click on the folder icon at the top of the window.

Continue Reading

Single Nucleotide Polymorphisms and the Central Nervous System: Potential Biomarkers in Identifying Suicide Risk

Single Nucleotide Polymorphisms and the Central Nervous System: Potential Biomarkers in Identifying Suicide Risk

| June 1, 2017 | 0 Comments

by Atmaram Yarlagadda, MD; Kevin P. Rosenblatt, MD, PhD; and Anita H. Clayton, MD Dr. Yarlagadda is Chief, Behavioral Health Services, McDonald Army Health Center in Newport News, Virginia, and Assistant Professor, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia; Dr. Rosenblatt is Adjunct Associate Professor, UT Health at Houston, Department of […]

Continue Reading

Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders

Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders

| February 1, 2016 | 2 Comments

by the CNS SUMMIT DATA QUALITY MONITORING WORKGROUP CORE MEMBERS—David Daniel, MD; Amir Kalali, MD; Mark West; David Walling, PhD; Dana Hilt, MD; Nina Engelhardt, PhD; Larry Alphs, MD, PhD; Antony Loebel, MD; Kim Vanover, PhD; Sarah Atkinson, MD; Mark Opler, PhD, MPH; Gary Sachs, MD; Kari Nations, PhD; and Chris Brady, PsyD Dr. Daniel […]

Continue Reading

The Neuroscience Report—Volume 24 (October 12, 2015): Treatment Paradigm Shifts in CNS

The Neuroscience Report—Volume 24 (October 12, 2015): Treatment Paradigm Shifts in CNS

| October 12, 2015 | 0 Comments

The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This Week’s Topic: Treatment […]

Continue Reading

Editor’s Message and Issue Highlights: May-June 2015

Editor’s Message and Issue Highlights: May-June 2015

| June 11, 2015 | 0 Comments

Dear Colleagues: Welcome to the May-June issue of Innovations in Clinical Neuroscience. First, I would like to call your attention to the accompanying supplement to this issue of the journal, a compendium of abstracts from the 2014 CNS Summit poster presentations. Each year, the CNS Summit brings together drug development leaders from pharma, research sites, […]

Continue Reading

A message from the chair, ISCTM Scientific Publications

A message from the chair, ISCTM Scientific Publications

| April 20, 2015 | 0 Comments

Dear Colleagues: Twice a year, the International Society for CNS Clinical Trials and Methodology (ISCTM) brings together academic researchers, policy makers, and industry and government representatives to focus on promoting advances in the development and use of central nervous system (CNS) therapeutic agents. Over the past few years, this forum has specifically addressed the strategic […]

Continue Reading

Editor’s Message and Issue Highlights: November-December 2014

Editor’s Message and Issue Highlights: November-December 2014

| December 7, 2014 | 0 Comments

Dear Colleagues: Welcome to the November–December 2014 issue of Innovations in Clinical Neuroscience. We start this issue with the first of what we hope to be a series of drug development guidance papers created by the collaborative efforts of the clinicians, investigators, industry scientists, and other entities involved in drug development who participate in the […]

Continue Reading

Consensus Recommendations on Rater Training and Certification

Consensus Recommendations on Rater Training and Certification

| December 7, 2014 | 0 Comments

by The CNS Summit Rater Training and Certification Committee: Mark D. West; David G. Daniel, MD; Mark Opler, PhD, MPH; Alexandria Wise-Rankovic, PhD; and Amir Kalali, MD Mr. West is Principal Consultant with Innovum Research, Las Vegas, Nevada (was with ePharmaSolutions, Plymouth Meeting, Pennsylvania, at the writing of this article); Dr. Daniel is Senior Vice President, […]

Continue Reading